Cerus Corporation Announces First Quarter 2026 Financial Results
Cerus Corporation reported strong financial results for the first quarter of 2026, driven by increased demand for their INTERCEPT Fibrinogen Complex. CEO William ‘Obi’ Greenman expressed confidence in the company’s performance and announced a raise in product revenue guidance for the year.
CONCORD, Calif.–(BUSINESS WIRE)–Cerus Corporation (Nasdaq: CERS) announced today financial results for the first quarter ended March 31, 2026, and provided a business update. “We delivered a strong start to 2026, with first quarter performance driven by strength across our business, in particular by increasing demand for our INTERCEPT Fibrinogen Complex,” said William “Obi” Greenman, Cerus’ president and chief executive officer. “As a result, we are raising our product revenue guidance for th